Neutralizing monoclonal antibody cocktail REGN-EB3 for Ebola virus disease (EVD)

Overview

Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness

Editors
World Health Organization
Number of pages
1
Reference numbers
WHO Reference Number: WHO/EVD/therapeutics/REGN-EB3/Poster_A/2022.1
Copyright